Clinical Trial Update: Use of Lipid Emulsion or Nanoemulsion of Propofol on Children Undergoing Ambulatory Invasive Procedures. [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating lipid-emulsion or nanoemulsion propofol in children undergoing ambulatory invasive procedures was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Propofol (lipid emulsion or nanoemulsion) (Propofol)

Snippet

Sponsor: Cristália Produtos Químicos Farmacêuticos Ltda. | Conditions: Leukemia | Phase 2, Phase 3 | Status: WITHDRAWN